This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Jain, A. Search for Related Content PubMed PubMed Citation Articles by Jain, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Social Bookmarking                         What's this?

Effectiveness of Bevantolol in the Treatment of Hypertension: Once-Daily Versus Twice-Daily Evaluation of Home Blood Pressure Measurements

Tulane University School of Medicine and Clinical Research Center, New Orleans, Louisiana

Two multicenter, double-blind, placebo-controlled studies were conducted to determine in patients with hypertension the oral dose of bevantolol that would effectively reduce home diastolic blood pressure to less than 95 mm Hg. The two studies differed only in once-daily or twice-daily dose administration. In the 125 patients evaluated, the mean decreases in home diastolic blood pressure were significantly greater in patients receiving 100 to 400 mg/day of bevantolol (8 to 10 mm Hg) than in patients receiving placebo (2 to 3mm Hg) (p < 0.05). Bevan tolol administered once daily or twice daily was equally effective in the manage ment of hypertension and was well tolerated in the doses studied.

Angiology, Vol. 37, No. 3, 239-245 (1986)
DOI: 10.1177/000331978603700316


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?